The extent of neurodegeneration in the earliest stages of central nervous system (CNS) demyelination is not known. Optical coherence tomography (OCT) is a powerful tool to study neurodegeneration in demyelinating disorders.
Objectives:
To study neuroaxonal loss in the retina of individuals with radiologically isolated syndrome (RIS) and investigate whether OCT measurements are associated with brain volumetrics and clinical conversion to multiple sclerosis (MS).
Methods:
Subjects fulfilling the Okuda criteria for RIS (n = 15 patients, 30 eyes) and age- and sex-matched healthy controls (HC) underwent spectral-domain OCT and magnetic resonance imaging for volumetric measurement of brain structures.
Results:
Macular ganglion cell-inner plexiform layer (mGCIPL), macular retinal nerve fiber layer (mRNFL), and temporal peripapillary RNFL (pRNFL) thickness; normalized total brain volume (nTBV); and normalized thalamic volume (nTV) were reduced in RIS compared to HC. mGCIPL, mRNFL, and pRNFL measurements were associated with nTBV, nTV, and normalized gray and white matter volumes in the RIS group. pRNFL was thinner in individuals with RIS who converted to MS in 5 years.
Conclusions:
Retinal neurodegeneration can be detected in the papillomacular region in the earliest stages of CNS demyelination and reflects global disease processes in the brain. OCT can be potentially useful for predicting prognosis in RIS.
OkudaDTMowryEMBeheshtianA, et al. Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome. Neurology2009; 72(9): 800–805.
2.
OkudaDTSivaAKantarciO, et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS One2014; 9(3): e90509.
3.
De StefanoNGiorgioATintoreM, et al. Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations. Mult Scler2018; 24(2): 214–221.
4.
KnierBBertheleABuckD, et al. Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination. Mult Scler2016; 22(7): 893–900.
5.
AzevedoCJOvertonEKhadkaS, et al. Early CNS neurodegeneration in radiologically isolated syndrome. Neurol Neuroimmunol Neuroinflamm2015; 2(3): e102.
6.
DorrJWerneckeKDBockM, et al. Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One2011; 6(4): e18132.
7.
LebrunCBensaCDebouverieM, et al. Unexpected multiple sclerosis: Follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry2008; 79(2): 195–198.
8.
OkudaDTMowryEMCreeBA, et al. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology2011; 76(8): 686–692.
9.
LebrunCBensaCDebouverieM, et al. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: Follow-up of 70 patients. Arch Neurol2009; 66(7): 841–846.
10.
Matute-BlanchCVillarLMAlvarez-CermenoJC, et al. Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome. Brain2018; 141(4): 1085–1093.
11.
PetzoldABalcerLJCalabresiPA, et al. Retinal layer segmentation in multiple sclerosis: A systematic review and meta-analysis. Lancet Neurol2017; 16(10): 797–812.
12.
BritzeJPihl-JensenGFrederiksenJL.Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: A systematic review and meta-analysis. J Neurol2017; 264(9): 1837–1853.
13.
Martinez-LapiscinaEHArnowSWilsonJA, et al. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: A cohort study. Lancet Neurol2016; 15(6): 574–584.
14.
AshburnerJ.Computational anatomy with the SPM software. Magn Reson Imaging2009; 27(8): 1163–1174.
15.
OberwahrenbrockTRingelsteinMJentschkeS, et al. Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler2013; 19(14): 1887–1895.
16.
PietroboniAMDell’ArtiLCaprioliM, et al. The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients. Mult Scler2019; 25: 31–38.
17.
MaghziAHGravesJRevirajanN, et al. Retinal axonal loss in very early stages of multiple sclerosis. Eur J Neurol2015; 22(7): 1138–1141.
18.
BalkLJCruz-HerranzAAlbrechtP, et al. Timing of retinal neuronal and axonal loss in MS: A longitudinal OCT study. J Neurol2016; 263(7): 1323–1331.
19.
EshaghiAMarinescuRVYoungAL, et al. Progression of regional grey matter atrophy in multiple sclerosis. Brain2018; 141(6): 1665–1677.
20.
AzevedoCJCenSYKhadkaS, et al. Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease. Ann Neurol2018; 83(2): 223–234.
21.
SchoonheimMMCiccarelliO.The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis. Neurology2018; 90(15): 677–678.
22.
FilippiMRoccaMAPaganiE, et al. Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage. J Neurol Neurosurg Psychiatry2014; 85(8): 851–858.
23.
GaetanoLHaringDARadueEW, et al. Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis. Neurology2018; 90(15): e1324–e1332.
24.
KaufholdFZimmermannHSchneiderE, et al. Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLoS One2013; 8(8): e71145.
25.
SaidhaSSotirchosESIbrahimMA, et al. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: A retrospective study. Lancet Neurol2012; 11(11): 963–972.
26.
KnierBSchmidtPAlyL, et al. Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis. Brain2016; 139(11): 2855–2863.
27.
BalkLJSteenwijkMDTewarieP, et al. Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. J Neurol Neurosurg Psychiatry2015; 86(4): 419–424.
28.
GabilondoIMartinez-LapiscinaEHMartinez-HerasE, et al. Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol2014; 75(1): 98–107.
29.
YoungKLBrandtAUPetzoldA, et al. Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis. Eur J Neurol2013; 20(5): 803–811.
30.
ZimmermannHFreingAKaufholdF, et al. Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Mult Scler2013; 19(4): 443–450.
31.
SaidhaSSotirchosESOhJ, et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol2013; 70(1): 34–43.
32.
ZivadinovRBergslandNCappellaniR, et al. Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients. Eur J Neurol2014; 21(8): 1137-e61.
33.
SaidhaSAl-LouziORatchfordJN, et al. Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study. Ann Neurol2015; 78(5): 801–813.
34.
YingGSMaguireMGGlynnR, et al. Tutorial on biostatistics: Statistical analysis for correlated binary eye data. Ophthalmic Epidemiol2018; 25(1): 1–12.
35.
YingGSMaguireMGGlynnR, et al. Tutorial on biostatistics: Linear regression analysis of continuous correlated eye data. Ophthalmic Epidemiol2017; 24(2): 130–140.
36.
HuangJHuangJChenY, et al. Evaluation of approaches to analyzing continuous correlated eye data when sample size is small. Ophthalmic Epidemiol2018; 25(1): 45–54.
37.
GelfandJMGoodinDSBoscardinWJ, et al. Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS One2012; 7(5): e36847.
38.
NarayananDChengHBonemKN, et al. Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis. Mult Scler2014; 20(10): 1331–1341.
